Theragenics Corporation

	NYSE: TGX	Change symbol:

PROFILE Theragenics helped New York City Mayor Rudolph Giuliani win a fight against cancer, but it couldn't win him a Senate seat. The firm's TheraSeed product, used to treat Giuliani's prostate cancer, is a radioactive implant about the size of a grain of rice. The seeds are implanted in early stage prostate tumors and release radiation that kills cancerous cells with minimal damage to surrounding healthy tissue. Palladium-103, produced in Theragenics' own cyclotrons, is the radiation source. Amersham (formerly Nycomed Amersham), Imagyn Medical Technologies, C.R. Bard, and Prostate Services of America market the seeds. Theragenics hopes to expand TheraSeed's use to macular degeneration, restenosis, and other cancers.  COMPETITION North American Scientific, Inc. (NASI) UroCor, Inc. (UCOR) UroMed Corporation (URMD)		STOCK ANALYSIS  View by:  Day   Day   Month   Month   Year   Year  FURTHER ANALYSIS • Advanced Charting • Deals  FINANCIAL OVERVIEW Fiscal Year-End: December 2000 Sales (mil.): 44.00 1-Yr. Sales Growth: 0.7% Employees: 145 Revenue per employee: $303,448.28  KEY PEOPLE • M. Christine Jacobs     CEO • Bruce W. Smith     CFO  CONTACT INFO 5203 Bristol Industrial Way Buford, GA 30518 US Phone: 770-271-0233 Fax: 770-831-4371 Online: Web Site

	Company Data   News, quotes & more

		Hoover's Company Capsule Copyright © 2001, Hoover's Inc. Austin, Texas. For changes and updates, contact Hoover's directly.